<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="4.3.2">Jekyll</generator><link href="https://calebaguayo.github.io/McNuttLab/feed.xml" rel="self" type="application/atom+xml" /><link href="https://calebaguayo.github.io/McNuttLab/" rel="alternate" type="text/html" /><updated>2024-08-14T18:15:07+00:00</updated><id>https://calebaguayo.github.io/McNuttLab/feed.xml</id><title type="html">McNutt Lab Website</title><subtitle>Explore the innovative research of a distinguished scientist and educator dedicated to unraveling the mysteries of toxicity and regeneration. Delve into cutting-edge studies ranging from molecular mechanisms to multi-organ responses, aimed at developing transformative therapies for human diseases. Join us in advancing scientific frontiers, fostering creativity, excellence, and mentorship for the scientists of tomorrow.</subtitle><entry><title type="html">New strategy to fight botulinum toxin - expert available</title><link href="https://calebaguayo.github.io/McNuttLab/2021/01/06/BotToxEurekA.html" rel="alternate" type="text/html" title="New strategy to fight botulinum toxin - expert available" /><published>2021-01-06T00:00:00+00:00</published><updated>2024-08-14T18:13:31+00:00</updated><id>https://calebaguayo.github.io/McNuttLab/2021/01/06/BotToxEurekA</id><content type="html" xml:base="https://calebaguayo.github.io/McNuttLab/2021/01/06/BotToxEurekA.html"><![CDATA[<p>Related to new research published in the January issue of Science Translational Medicine, Patrick McNutt, PhD, of the Wake Forest Institute for Regenerative Medicine, was part of the research team that demonstrated a new “Trojan horse” approach that produces strong antidotal efficacy in treating lethal botulism in mice, guinea pigs and rhesus macaque monkeys.</p>]]></content><author><name>EurekAlert!</name></author><summary type="html"><![CDATA[Related to new research published in the January issue of Science Translational Medicine, Patrick McNutt, PhD, of the Wake Forest Institute for Regenerative Medicine, was part of the research team that demonstrated a new “Trojan horse” approach that produces strong antidotal efficacy in treating lethal botulism in mice, guinea pigs and rhesus macaque monkeys.]]></summary><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://school.wakehealth.edu/research/institutes-and-centers/wake-forest-institute-for-regenerative-medicine/awards-honors-and-media-coverage/2022/new-research-shows-drug-used-to-treat-neuromuscular-weakness-could-counter-botulism" /><media:content medium="image" url="https://school.wakehealth.edu/research/institutes-and-centers/wake-forest-institute-for-regenerative-medicine/awards-honors-and-media-coverage/2022/new-research-shows-drug-used-to-treat-neuromuscular-weakness-could-counter-botulism" xmlns:media="http://search.yahoo.com/mrss/" /></entry></feed>